Patents by Inventor Minliang XIAO

Minliang XIAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused ring derivative as Areceptor inhibitor
    Patent number: 11312715
    Abstract: Disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and an application of the compound or slat in preparation of drugs for treating diseases related to an A2A receptor.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: April 26, 2022
    Assignees: CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD., CSTONE PHARMACEUTICALS (SHANGHAI) CO., LTD., CSTONE PHARMACEUTICALS
    Inventors: Kevin X Chen, Kai Zhou, Boyu Hu, Minliang Xiao, Shuhui Chen
  • ?-lactamase inhibitors
    Patent number: 10738051
    Abstract: Disclosed in the present invention is a type of novel ?-lactamase inhibitors, and specifically disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: August 11, 2020
    Assignee: QILU PHARMACEUTICAL CO., LTD.
    Inventors: Boyu Hu, Charles Z. Ding, Zhigang Huang, Ruibin Lin, Minliang Xiao, Jinsheng Xie, Shuhui Chen, Cheng Li
  • FUSED RING DERIVATIVE AS A2A RECEPTOR INHIBITOR
    Publication number: 20200239465
    Abstract: Disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and an application of the compound or slat in preparation of drugs for treating diseases related to an A2A receptor.
    Type: Application
    Filed: September 27, 2018
    Publication date: July 30, 2020
    Inventors: Kevin X CHEN, Kai ZHOU, Boyu HU, Minliang XIAO, Shuhui CHEN
  • NOVEL BETA-LACTAMASE INHIBITORS
    Publication number: 20200010467
    Abstract: Disclosed in the present invention is a type of novel ?-lactamase inhibitors, and specifically disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 2, 2017
    Publication date: January 9, 2020
    Applicant: MEDSHINE DISCOVERY INC.
    Inventors: Boyu HU, Charles Z. DING, Zhigang HUANG, Ruibin LIN, Minliang XIAO, Jinsheng XIE, Shuhui CHEN, Cheng LI